Cochlear | COH - Net Income

Stock Price
93.52
Daily Change
-2.81 -2.92%
Monthly
-45.21%
Yearly
-65.50%
Q2 Forecast
94.51

Cochlear reported AUD161.5M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Ansell USD 88.8M 65.5M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Fisher Paykel Healthcare NZD 213M 11M Dec/2025
Healius AUD -12.8M 7.8M Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103.68M 68.4M Jun/2024
Mesoblast USD -40.16M 14.05M Dec/2025
Monash IVF AUD 7.16M 3.16M Dec/2025
Nanosonics AUD 9.64M 4.18M Dec/2025
Polynovo AUD 3K 9.87M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
Regis Healthcare AUD 13.44M 1.14M Dec/2025
ResMed USD 392.59M 44.05M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Somnomed AUD -4.25M 509.26K Jun/2023
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025